Tzu Chi Medical Journal
Volume 20, Issue 1 , Pages 35-39, March 2008

Treatment Strategies for Neurogenic Voiding Dysfunction

  • Hann-Chorng Kuo

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Urology, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan

Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan

Received 26 September 2007; received in revised form 17 October 2007; accepted 23 October 2007.

Article Outline

Abstract 

The main problems in neurogenic voiding dysfunction (NVD) are failure to store, failure to empty, and combined failure to store and empty. The management priorities in NVD should be as follows, in order: (1) preservation of renal function, (2) freedom from urinary tract infection, (3) efficient bladder emptying, (4) freedom from an indwelling catheter, (5) patient satisfaction with voiding management and (6) avoiding medication after proper management. Management of the urinary tract in patients with spinal cord injury must be based on urodynamic findings rather than inferences from a neurologic evaluation. Selecting high-risk patients is important to prevent renal function impairment in patients with chronic NVD. Patients with NVD should be regularly followed-up for lower urinary tract dysfunction using urodynamic study and any urological complication should be adequately treated. Avoiding a chronic indwelling catheter can reduce the incidence of developing a low compliant bladder. Intravesical instillation of vanilloids or injection of BOTOX provides an alternative treatment for refractory detrusor overactivity or low compliant bladder and can replace the need for bladder augmentation. When surgical intervention is necessary, a less invasive type of surgery and a reversible procedure should be considered first and unnecessary surgery in the lower urinary tract should be avoided. Keeping the bladder and urethra in good condition without interfering with neuromuscular continuity will give patients with NVD a chance to benefit from new technologies in the future. It is most important that the physician continues to try to improve the quality of life of patients with NVD. [Tzu Chi Med J 2008;20(1):35–39]

Keywords:  Lower urinary tract dysfunction , Neurogenic bladder , Urological complication

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Weld KJ , Dmochowski RR . Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury . Urology . 2000;55:490–494
  2. Wyndaele JJ , Madersbacher H , Kovindha A . Conservative treatment of the neuropathic bladder in spinal cord injured patients . Spinal Cord . 2001;39:294–300
  3. Chancellor MB , Anderson RU , Boone TB . Pharmacotherapy for neurogenic detrusor overactivity . Am J Phys Med Rehabil . 2006;85:536–545
  4. Reitz A , Knapp PA , Muntener M , Schurch B . Oral nitric oxide donors: a new pharmacological approach to detrusorsphincter dyssynergia in spinal cord injured patients? . Eur Urol . 2004;45:516–520
  5. Ruqqieri MR , Braverman AS , Pontari MA . Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction . J Urol . 2005;174:1743–1748
  6. Chandiramani VA , Peterson T , Duthie GS , Fowler CJ . Urodynamic changes during therapeutic intravesical instillations of capsaicin . Br J Urol . 1996;77:792–797
  7. Igawa Y , Satoh T , Mizusawa H , et al.   The role of capsaicinsensitive afferents in autonomic dysreflexia in patients with spinal cord injury . BJU Int . 2003;91:637–641
  8. Shin JC , Kim YW , Park CI , Kang SW , Yang SC . Effect of the intravesical resiniferatoxin instillation evaluated by the ice pro vocative urodynamic study . Spinal Cord . 2006;44:309–314
  9. Kuo HC . Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics . BJU Int . 2005;95:1023–1027
  10. Perkash I . Transurethral sphincterotomy provides significant relief in autonomic dysreflexia in spinal cord injured male patients: long-term follow-up results . J Urol . 2007;177:1026–1029
  11. Perkash I . Contact laser sphincterotomy: further experience and longer follow-up . Spinal Cord . 1996;34:227–233
  12. Seoane-Rodríguez S , Sánchez R-Losada J , MontotoMarqués A , et al.   Long-term follow-up study of intraurethral stents in spinal cord injured patients with detrusor-sphincter dyssynergia . Spinal Cord . 2007;45:621–626
  13. Quek ML , Ginsberg DA . Long-term urodynamic follow-up of bladder augmentation for neurogenic bladder . J Urol . 2003;169:195–198
  14. Blaivas JG , Weiss JP , Desai P , Flisser AJ , Stember DS , Stahl PJ . Long-term follow-up of augmentation enterocystoplasty and continent diversion in patients with benign disease . J Urol . 2005;173:1631–1634
  15. Zommick JN , Simoneau AR , Skinner DG , Ginsberg DA . Continent lower urinary tract reconstruction in the cervical spinal cord injured population . J Urol . 2003;169:2184–2187
  16. Schurch B , Stohrer M , Kramer G , Schmid DM , Gaul G , Hauri D . Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results . J Urol . 2000;164:692–697
  17. Ehren I , Volz D , Farrelly E , et al.   Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity . Scand J Urol Nephrol . 2007;41:335–340
  18. Patki PS , Hamid R , Arumugam K , Shah PJ , Craggs M . Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury . BJU Int . 2006;98:77–82
  19. Riccabona M , Koen M , Schindler M , et al.   Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia . J Urol . 2004;171:845–848
  20. Kajbafzadeh AM , Moosavi S , Tajik P , et al.   Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele . Urology . 2006;68:1091–1096
  21. Akbar M , Abel R , Seyler TM , et al.   Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction . BJU Int . 2007;100:639–645
  22. Gianantoni A , Mearini E , Di Stasi SM , et al.   New therapeutic options for refractory neurogenic detrusor overactivity . Minerva Urol Nefrol . 2004;56:79–87
  23. Kuo HC . Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction . J Urol . 2003;170:1908–1912
  24. Chen YH , Kuo HC . Botulinum A toxin treatment of urethral sphincter pseudodyssynergia in patients with cerebrovascular accidents or intracranial lesions . Urol Int . 2004;73:156–162
  25. Lawrenson R , Wyndaele JJ , Vlachonikolis I , Farmer C , Glickman S . Renal failure in patients with neurogenic lower urinary tract dysfunction . Neuroepidemiology . 2001;20:138–143
  26. Weld KJ , Graney MJ , Dmochowski RR . Difference in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients . J Urol . 2000;163:1228–1233
  27. Schurch B , Denys P , Kozma CM , Reese PR , Slaton T , Barron R . Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence . Arch Phys Med Rehabil . 2007;88:646–652
  28. Reitz A , Stohrer M , Kramer G , et al.   European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity . Eur Urol . 2004;45:510–515
  29. Kuo HC . Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions . Urology . 2006;67:232–236
  30. Cheng H , Liao KK , Liao SF , Chuang TY , Shih YH . Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia . Spine . 2004;29:E284–E288
  31. Mitsui T , Fischer I , Shumsky JS , Murray M . Transplants of fibroblasts expressing BDNF and NT-3 promote recovery of bladder and hindlimb function following spinal contusion injury in rats . Exp Neurol . 2005;194:410–431
  32. Mitsui T , Kakizaki H , Tanaka H , Shibata T , Matsuoka I , Koyanagi T . Immortalized neural stem cells transplanted into the injured spinal cord promote recovery of voiding function in the rat . J Urol . 2003;170:1421–1425
  33. Xiao CG , Du MX , Li B , et al.   An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spinal bifida . J Urol . 2005;173:2112–2116
  34. Kivshits A , Catz A , Folman Y , et al.   Reinnervation of the neurogenic bladder in the late period of the spinal cord trauma . Spinal Cord . 2004;42:211–217
  35. Spinelli M , Malaguti S , Giardiello G , et al.   A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data . Neurourol Urodyn . 2005;24:305–309
  36. Kutzenberger J , Domurath B , Sauerwein D . Spastic bladder and spinal cord injury: seventeen years of experience with sacral deafferentiation and implantation of an anterior root stimulator . Artif Organs . 2005;29:239–241
  37. Vastenholt JM , Snoek GJ , Buschman HP , van der Aa HE , Alleman ER , Ijzerman MJ . A 7-year follow-up of sacral anterior root stimulation for bladder control in patients with a spinal cord injury: quality of life and users' experiences . Spinal Cord . 2003;41:397–402
  38. Obara T , Matsuura S , Narita S , Satoh S , Tsuchiya N , Habuchi T . Bladder acellular matrix grafting regenerates urinary bladder in the spinal cord injury rat . Urology . 2006;68:892–897
  39. Urakami S , Shiina H , Enokida H , et al.   Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat . World J Urol . 2007;25:207–213

PII: S1016-3190(08)60005-1

doi:10.1016/S1016-3190(08)60005-1

Tzu Chi Medical Journal
Volume 20, Issue 1 , Pages 35-39, March 2008

Article Tools